Skip to content

Avanos Medical AVNS Repayments of Lines of Credit

Repayments of Lines of Credit at other companies

AMN Healthcare logo
AMN HealthcareAMN
$25M-73.7%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLinesOfCredit.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's repayments of lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's repayments of lines of credit?
Avanos Medical (AVNS) reported repayments of lines of credit of $0 in Q1 2026.
How has Avanos Medical's repayments of lines of credit changed year-over-year?
Avanos Medical's repayments of lines of credit decreased by 100.0% year-over-year, from $25M to $0.
What does repayments of lines of credit mean?
Measures the cash outflows used to pay down outstanding balances on revolving credit facilities or lines of credit. This demonstrates the company's ability to manage short-term debt and improve its net debt position.